Modulation of epidermal growth factor receptor-positive circulating tumor cells by chemotherapy in non-small-cell lung cancer patients

被引：2
|
作者：
Normanno, N [1 ]
De Luca, A
Maiello, MR
Gridelli, C
机构：
[1] INT Fdn Pascale, Cell Biol & Preclin Models Unit, Naples, Italy
[2] SG Moscanti Hosp, Div Med Oncol, Avellino, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 30期
关键词：
D O I：
10.1200/JCO.2005.02.7755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7746 / 7748
页数：3
相关论文
共 50 条
  • [1] Modulation of epidermal growth factor receptor-positive circulating tumor cells by chemotherapy in non-small-cell lung cancer patients - Reply
    De Pas, T
    de Braud, F
    Spaggiari, L
    Pelosi, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) : 7748 - 7748
  • [2] Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer
    Lee, Kyung-Hun
    Han, Sae-Won
    Hwang, Pil Gyu
    Oh, Do-Youn
    Kim, Dong-Wan
    Chung, Doo Hyun
    Im, Seock-Ah
    Kim, Tae-You
    Heo, Dae Seog
    Bang, Yung-Jue
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (06) : 344 - 350
  • [3] Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rare
    De Pas, T
    Pelosi, G
    de Brand, F
    Veronesi, G
    Curigliano, G
    Leon, ME
    Danesi, R
    Noberasco, C
    d'Aiuto, M
    Catalano, G
    Viale, G
    Spaggiari, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (24) : 4966 - 4970
  • [4] EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY IN NON-SMALL-CELL LUNG CANCER
    Scagliotti, G. V.
    Novello, S.
    Levra, M. G.
    ANNALS OF ONCOLOGY, 2012, 23 : 12 - 12
  • [5] Epidermal growth factor receptor inhibitors in non-small-cell lung cancer
    Cascone, Tina
    Martinelli, Erika
    Morelli, Maria Pia
    Morgillo, Floriana
    Troiani, Teresa
    Ciardiello, Fortunato
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (03) : 335 - 348
  • [6] Circulating immune response proteins predict the outcome following disease progression of osimertinib treated epidermal growth factor receptor-positive non-small-cell lung cancer patients
    Maansson, Christoffer T.
    Helstrup, Sofie
    Ebert, Eva B. F.
    Meldgaard, Peter
    Sorensen, Boe S.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (01) : 14 - +
  • [7] Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer
    Morita, Meiko
    Ono, Akira
    Sekikawa, Motoki
    Doshita, Kosei
    Miura, Keita
    Kodama, Hiroaki
    Yabe, Michitoshi
    Morikawa, Noboru
    Iida, Yuko
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Ko, Ryo
    Wakuda, Kazushige
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Isaka, Mitsuhiro
    Ohde, Yasuhisa
    Takahashi, Toshiaki
    CANCER REPORTS, 2024, 7 (09)
  • [8] Suramin inhibits the growth of non-small-cell lung cancer cells that express the epidermal growth factor receptor
    Fujiuchi, S
    Ohsaki, Y
    Kikuchi, K
    ONCOLOGY, 1997, 54 (02) : 134 - 140
  • [9] Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer
    Zhang, Xiaozhu
    Chang, Alex
    JOURNAL OF MEDICAL GENETICS, 2007, 44 (03) : 166 - 172
  • [10] Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer
    Kotsakis, Athanasios
    Georgoulias, Vassilis
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (14) : 2363 - 2389
12345